Biotech

All Articles

Amgen records first phase 3 gain for $400M eczema medicine

.Amgen has shared (PDF) the initial stage 3 records on its own $400 thousand eczema drug, connecting...

Biogen, UCB document period 3 lupus succeed after neglecting earlier trial

.Biogen and UCB's rely on advancing in to stage 3 astride a broken research aims to have paid off, a...

Aptadir wishes brand new RNA preventions can reverse difficult cancers

.Italian biotech Aptadir Rehabs has actually released along with the guarantee that its own pipe of ...

Wave surfs DMD excellence to regulatory authorities' doors, sending out stockpile

.Wave Lifestyle Sciences has satisfied its goal in a Duchenne muscular dystrophy (DMD) research, pos...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma layer, tak...

Achilles drops cell treatment plan, braces for layoffs after skipping 'industrial practicality' objectives

.Achilles Rehabs has wrecked its approach. The English biotech is stopping work on its clinical-phas...

Aligos proclaims period 2 MASH win, reducing liver fat approximately 46%

.Aligos Therapeutics is actually declaring a midstage gain in metabolic-dysfunction affiliated steat...

Basilea scores $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's work building new antifungals has actually gotten a substantial boost from ...

Capricor offers Europe civil liberties to late-stage DMD treatment for $35M

.Having currently scooped up the USA civil liberties to Capricor Therapies' late-stage Duchenne musc...

FDA fragments adcomm for Applied's unusual disease medication

.After pushing the selection date for Applied Therapies' metabolic condition medicine govorestat, th...